This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Hermann FH, Auerswald G, Ruiz-Saez A, et al. Factor X deficiency: clinical manifestation of 102 subjects from Europe and Latin America with mutations in the factor 10 gene. Haemophilia 2006; 12: 479-489. doi: 10.1111/j.1365-2516.2006.01303.x.HermannFHAuerswaldGRuiz-SaezA.Factor X deficiency: clinical manifestation of 102 subjects from Europe and Latin America with mutations in the factor 10 gene.2006;12:479-489. doi:10.1111/j.1365-2516.2006.01303.x.Open DOISearch in Google Scholar
Brown DL, Kouides PA. Diagnosis and treatment of inherited factor X deficiency. Haemophilia 2008; 14: 1176-1182. doi: 10.1111/j.1365-2516.2008.01856.x.BrownDLKouidesPA.Diagnosis and treatment of inherited factor X deficiency.2008;14:1176-1182. doi:10.1111/j.1365-2516.2008.01856.x.Open DOISearch in Google Scholar
Tarantino MD. Occurrence and management of severe bleeding episodes in patients with hereditary factor X deficiency. Haemophilia 2021; 27(4): 531-543. doi:10.1111/ hae.14223.TarantinoMD.Occurrence and management of severe bleeding episodes in patients with hereditary factor X deficiency.2021;27(4):531-543. doi:10.1111/hae.14223.Open DOISearch in Google Scholar
National Organization for Rare Disorders. Factor X Deficiency. Published 2018, 2023. Last updated 6 June 2023. Available from https://rarediseases.org/rare-diseases/factor-x-deficiency/ (accessed November 2023).National Organization for Rare Disorders..Published 2018, 2023. Last updated 6 June 2023.Available from https://rarediseases.org/rare-diseases/factor-x-deficiency/(accessed November 2023).Search in Google Scholar
National Bleeding Disorders Foundation. Factor X (Stuart- Prower Factor) Deficiency. Available from https://www. hemophilia.org/bleeding-disorders-a-z/types/other-factor-deficiencies/factor-x (accessed November 2023).National Bleeding Disorders Foundation..Available from https://www.hemophilia.org/bleeding-disorders-a-z/types/other-factor-deficiencies/factor-x(accessed November 2023).Search in Google Scholar
Peyvandi F, Di Michele D, Bolton-Maggs PH, et al. Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity. J Thromb Haemost 2012; 10(9): 1938-1943. doi:10.1111/j.1538-7836.2012.04844.x.PeyvandiFDi MicheleDBolton-MaggsPH.Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity.2012;10(9):1938-1943. doi:10.1111/j.1538-7836.2012.04844.x.Open DOISearch in Google Scholar
Menegatti M, Peyvandi F. Factor X deficiency. Semin Thromb Hemost 2009; 35(4): 407-415. doi: 10.1055/s-0029-1225763.MenegattiMPeyvandiF.Factor X deficiency.2009;35(4):407-415. doi:10.1055/s-0029-1225763.Open DOISearch in Google Scholar
Branchford B, Clark K, Stanford R, et al. Hereditary Factor X Deficiency in America Survey: Impact on quality of life and burden of disease in patients and caregivers. Manuscript submitted for publication.BranchfordBClarkKStanfordR..Manuscript submitted for publication.Search in Google Scholar
Pall R, Peyvandi F, Shapiro AD. Rare bleeding disorders: diagnosis and treatment. Blood 2015; 125(13): 2052-2061. doi: 10.1182/blood-2014-08-532820.PallRPeyvandiFShapiroAD.Rare bleeding disorders: diagnosis and treatment.2015;125(13):2052-2061. doi:10.1182/blood-2014-08-532820.Open DOISearch in Google Scholar
Borboruah L, Dutta A. Management of a patient with factor X deficiency with FEIBA: a case report. J Haem Pract 2023; 10(1), 68-73. doi: 10.2478/jhp-2023-0012.BorboruahLDuttaA.Management of a patient with factor X deficiency with FEIBA: a case report.2023;10(1),68-73. doi:10.2478/jhp-2023-0012.Open DOISearch in Google Scholar
Masacupan KD, Racho AR, Del Rosario ML, Lagara-Aranas LM. The first reported case of factor x deficiency in a Filipino Child - case study. J Haem Pract 2023; 10(1): 90-94. doi: 10.2478/ jhp-2023-0015.MasacupanKDRachoARDel RosarioMLLagara-AranasLM.The first reported case of factor x deficiency in a Filipino Child - case study.2023;10(1):90-94. doi:10.2478/jhp-2023-0015.Open DOISearch in Google Scholar
National Bleeding Disorders Foundation. MASAC Document 280. MASAC Recommendations Concerning Products Licensed for the Treatment of Hemophilia and Selected Disorders of the Coagulation System. 2023. Available from https://www.hemophilia.org/healthcare-professionals/ guidelines-on-care/masac-documents/masac-document-280-masac-recommendations-concerning-products-licensed-for-the-treatment-of-hemophilia-and-selected-disorders-of-the-coagulation-system (accessed November 2023).National Bleeding Disorders Foundation..2023.Available from https://www.hemophilia.org/healthcare-professionals/guidelines-on-care/masac-documents/masac-document-280-masac-recommendations-concerning-products-licensed-for-the-treatment-of-hemophilia-and-selected-disorders-of-the-coagulation-system(accessed November 2023).Search in Google Scholar
Peyvandi F, Auerswald G, Austin SK, et al. Diagnosis, therapeutic advances, and key recommendations for the management of factor X deficiency. Blood Rev 2021; 50: 100833. doi: 10.1016/j.blre.2021.100833.PeyvandiFAuerswaldGAustinSK.Diagnosis, therapeutic advances, and key recommendations for the management of factor X deficiency.2021;50:100833. doi:10.1016/j.blre.2021.100833.Open DOISearch in Google Scholar